PHAC says the manufacturer requires a minimum order of its updated protein-based vaccine, called Nuvaxovid, which far exceeds the uptake by Canadians last year.
The European Pharmacovigilance Risk Assessment Committee reviewed reported cases and post-marketing safety data to evaluate the risks of PRES and RCVS with pseudoephedrine-containing medicines.
Researchers at the University of British Columbia have identified the cellular and molecular mechanisms, induced by a class of antibiotics, that can lead to respiratory allergies.